UNSPSC 51152015: Afloqualone

This classification denotes a muscle relaxant with the molecular formula C16H14FN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CO4U2C8ORZ, chemically known as 6-amino-3,4-dihydro-2-fluoromethyl-3-(2-methylphenyl)-4-chinazolinon but generally known as afloqualone, which bears US NIH Compound Identifier 2040. European Medicines Agency schedules Afloqualone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05281MIG.

UNSPSC 51152015 Afloqualone is a Commodity code that describes pharmaceutical products state and local governments procure for community health and public safety initiatives. The code sees application in competitive bidding for naloxone and drug deactivation systems — products designed to support overdose response and substance-abuse mitigation programs within county and municipal health systems. State and local purchasing offices, particularly county health departments and community health agencies, issue solicitations under this code to stock emergency medical supplies and harm-reduction equipment for public distribution and clinical use.

Seminole County, Florida, posted an IFB for 1,900 units of naloxone and 800 safe drug deactivation systems with a response deadline of July 26, 2023, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement included standard compliance requirements such as E-Verify authorization, drug-free workplace certification, and commercial general liability insurance. The source reflects a single recent opportunity from a Florida county health system; no other state or local jurisdictions appear in the recent-opportunities block, and geographic spread across other states cannot be determined from the available data.